Many analysts want to talk WACC or get an update on a trial that is BLINDED and you can’t legally say anything about.
Simon wanted to talk about science, patients, markets, culture, new programs. One of the top analysts and one of the few I looked forward to chatting with as I
I'm really grateful that @RecursionChris has chosen to join @_DimensionCap. I'm fortunate to be able to speak and learn from him so regularly.
When I was getting started on the buy-side, I initially focused entirely on public companies. I was lucky enough to meet Chris and his




